Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats

被引:11
作者
Hara, K [1 ]
Kobayashi, N [1 ]
Nakano, S [1 ]
Mori, Y [1 ]
Tsubokou, Y [1 ]
Matsuoka, H [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
关键词
angiotensin II type 1 receptor antagonist; endothelin; gene expression; PDGF;
D O I
10.1291/hypres.24.55
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II(Ang II) has been shown to stimulate cardiac growth and collagen synthesis in cultured vascular smooth muscle cells and to increase fibroblast proliferation. Chronic infusion with Ang II increases blood pressure and activates growth mechanisms to produce hypertrophy of the heart. This study investigated the effects of an Ang II type 1 receptor antagonist, TCV-116, on preproendothelin-l (preproET-1), ETA receptor and platelet-derived growth factor(PDGF) A-chain expression in the left ventricle of Wistar-Kyoto rats treated for 2 weeks with Ang II (200 ng.kg(-1).min(-1)), and the relation of these effects to myocardial remodeling. Rats given Ang II alone (ANGII-V) were compared with rats also receiving TCV-116(ANGII-TCV), In both groups, blood pressure was similar and significantly higher than in control rats. The preproET-1, ETA receptor and PDGF A-chain expressions in the left ventricle were significantly increased in ANGII-V compared with control rats, and were significantly suppressed in ANGII-TCV compared with ANGII-V rats. ANGII-V rats showed a significant increase of the type I collagen expression, wall-to-lumen ratio, perivascular fibrosis, and myocardial fibrosis, with all these parameters being significantly improved by TCV-116. Myocardial remodeling in Ang Ii-induced hypertensive rats was significantly ameliorated by a subdepressor dose of TCV-116, which may have been due to a decrease in ET-1 and PDGF A-chain expression in the left ventricle.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 53 条
[1]   Losartan improves diastolic ventricular filling of hypertensive patients with diastolic dysfunction [J].
Ayoub, JCA ;
Vitola, JV ;
Parro, A ;
Costa, OMC ;
Delgado, AS ;
de Parma, AHC ;
Takakura, IT .
HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (02) :155-159
[2]   ANGIOTENSIN-II STIMULATION OF PROTEIN-SYNTHESIS AND CELL-GROWTH IN CHICK HEART-CELLS [J].
BAKER, KM ;
ACETO, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H610-H618
[3]   VASOCONSTRICTION - A NEW ACTIVITY FOR PLATELET-DERIVED GROWTH-FACTOR [J].
BERK, BC ;
ALEXANDER, RW ;
BROCK, TA ;
GIMBRONE, MA ;
WEBB, RC .
SCIENCE, 1986, 232 (4746) :87-90
[4]   Multiple intracellular MAP kinase signaling cascades [J].
Bokemeyer, D ;
Sorokin, A ;
Dunn, MJ .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1187-1198
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   REGULATION OF ENDOTHELIN-1 MESSENGER-RNA BY ANGIOTENSIN-II IN RAT-HEART ENDOTHELIAL-CELLS [J].
CHUA, BHL ;
CHUA, CC ;
DIGLIO, CA ;
SIU, BB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1178 (02) :201-206
[8]   Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase -: Role of blood pressure and endothelial function [J].
d'Uscio, LV ;
Shaw, S ;
Barton, M ;
Lüscher, TF .
HYPERTENSION, 1998, 31 (06) :1305-1310
[9]   Left ventricular hypertrophy in hypertension: Stimuli, patterns, and consequences [J].
Devereux, RB ;
Roman, MJ .
HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (01) :1-9
[10]   CELLULAR MECHANISM OF ENDOTHELIN-1 RELEASE BY ANGIOTENSIN AND VASOPRESSIN [J].
EMORI, T ;
HIRATA, Y ;
OHTA, K ;
KANNO, K ;
EGUCHI, S ;
IMAI, T ;
SHICHIRI, M ;
MARUMO, F .
HYPERTENSION, 1991, 18 (02) :165-170